alprostadil liposome / CSPC Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
alprostadil liposome / CSPC Pharma
NCT05475717: A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI

Terminated
2
132
RoW
Alprostadil liposome injection, Alprostadil liposome
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Contrast-induced Acute Kidney Injury
12/23
01/24

Download Options